Pangenotypic Regimens and the Next Generation of HCV Treatment
AASLD LiverLearning®. Reau N. Nov 14, 2016; 154728
Topic: Treatment
Label: HCV Symposium: Challenges in the DAA Era
Dr. Nancy Reau
Dr. Nancy Reau

AASLD Members enjoy free LiverLearning® Premium Access. Registrants of The Liver Meeting® receive LiverLearning® Premium Access for one year from the first day of the meeting. A LiverLearning® Subscription ($150.00 US) grants access to LiverLearning® Premium content for one year after date of purchase. Click here to purchase your Premium Access Subscription now.


Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions